A three-pronged approach was followed for deducing the gene expression market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for gene expression market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of gene expression market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The gene expression market was categorized into six segments, namely process (Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation), product (Kits & Reagents, DNA Chips), capacity (Low- to Mid- Plex, High-Plex), application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology), technique (RNA Expression, Promoter Analysis, Protein Expression & Posttranslational Modification Analysis), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
The gene expression market was segmented into process, product, capacity, application, technique, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The gene expression market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; India; Japan; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa, Saudi Arabia; UAE; Kuwait.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The gene expression market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
Qiagen – Qiagen is a public limited company catering to the needs of biotechnology industry. Qiagen provides sample and assay technologies for academic research, applied testing, molecular diagnostics, and pharmaceutical research. The company markets over 500 products including consumable kits and automation systems.
Quest Diagnostics Incorporated – Quest Diagnostics Inc. is a clinical laboratory services provider. It was known as Metropolitan Pathology Laboratory, Inc. in 1967, which later became an independent corporation in 1997. The company has its administrative offices in Lyndhurst, Collegeville, and Pennsylvania.
F. Hoffmann-La Roche Ltd - F. Hoffmann-La Roche Ltd is primarily involved in development and supply of diagnostic and pharmaceutical products to healthcare companies and healthcare providers. It has around 26 manufacturing sites and 22 R&D sites worldwide. It operates through two segments: pharmaceuticals and diagnostics.
Illumina, Inc. – Illumina, Inc. is primarily involved in the manufacture, development, and distribution of integrated platforms & systems for sequencing, analysis, and investigation of genomic & proteomic information, and its biological function & expression. The company provides NGS platforms for genotyping, sequencing, and gene expression analysis.
Bio-Rad Laboratories Inc. – Bio-Rad Laboratories, Inc. manufactures systems and products used in separating complex biological & chemical materials. In addition, it allows identification, purification, and analysis of biological & chemical components. The company operates in two segments: clinical diagnostics, and life sciences.
Thermo Fisher Scientific, Inc. - Thermo Fisher Scientific, Inc. develops, manufactures, and provides laboratory reagents, equipment, analytical instruments, and consumables. The company resulted from the merger of Fisher Scientific and Thermo Electron. It operates through various brands such as Thermo Scientific, Applied Biosystems, Fisher Scientific, Invitrogen, and Unity Lab Services.
Promega Corporation - Promega Corporation is an independent and privately held company that offers products and services for life science research and industries. These include biotechnology & pharmaceutical industries, clinical & molecular diagnostics, applied biotechnology & agriculture, forensics & paternity research, and government & academic research institutes.
Danaher - Danaher is involved in development and manufacturing of products for medical, commercial, industrial, and research applications. These are categorized into four business segments: diagnostics, life sciences, dental, and environmental & applied solutions.
Interpace Diagnostics, LLC - Interpace Diagnostics, LLC is a subsidiary of Interpace Diagnostics Group, Inc. It is involved in the development and commercialization of molecular diagnostic tests and personalized medicine by leveraging technology. Currently, the company has three commercial products: ThyGenX, PancraGEN, and ThyraMIR.
Luminex Corporation - Luminex Corporation is involved in development, manufacturing, and sale of biological test products & technologies. The company’s target customers include pharmaceutical, diagnostics, and life science industries. Its key products include xMAP, xTAG, Verigene, and MultiCode Technologies.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
GET A FREE SAMPLE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member